© 2014 Antietam Oncology & Hematology Group, PC • 1130 Opal Court, Hagerstown, MD 21740 • 301-797-8279
Clinical Trials
Providing 20 Years of quality cancer care to the community.

Antietam Oncology & Hematology Group, PC • Hagerstown, Md

Design & Hosting by LogoCrate.com


Amgen Prospective study of the relationship between chemotherapy dose intensity and mortality in early-stage (I-II) breast cancer patients. Hoosier A phase II randomized controlled trial of genomically directed therapy after preoperative chemotherapy in patients with triple negative breast cancer.


E1412 Randomized phase II open label study of Lenalidomide R-Chop (R2CHOP Vs RCHOP (Rituximab_Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in patients with newly diagnosed diffuse large B cell Lymphoma. Inform CLL A Disease Registry for patients with chronic Lymphocytic Leukemia

Reveal Study

Reveal study is a Prospective observational study of patients with polycythemia Vera in US clinical practices; to describe the clinical burden of PV, and to Describe health care resources utilization associated with the management of PV.

Iron Clad

can lron lessen anemia due to cancer and chemotherapy. A multi-center, randomized, double-blind, study to investigate controlled the efficacy and safety of injectafer (ferric carboxymaltose injection)
Hematological Studies
The following clinical trials and studies are available.  For more information or questions please contact us.